Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19Michael A. Thompson, KM Steve Lo, Peter Paul Yu et al.|JAMA Oncology|2021Cited by 185
Use of Natural Language Processing to Extract Clinical Cancer Phenotypes from Electronic Medical RecordsGuergana Savova, Jeremy L. Warner, Ioana Danciu et al.|Cancer Research|2019Cited by 175
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort StudyDonna R. Rivera, Jeremy L. Warner, Solange Peters et al.|Cancer Discovery|2020Cited by 138
Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic SyndromesWade T. Iams, Christine M. Lovly, Eileen Shiuan et al.|Journal of Thoracic Oncology|2019Cited by 76
The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19Ang Li, Rachel Rosovsky, Nicole M. Kuderer et al.|Journal of Thrombosis and Haemostasis|2021Cited by 30